Key points are not available for this paper at this time.
Symptoms' distribution supports specific clinical phenotypes without overlap between LE and MoS. The distinct immunogenetic characteristics shared by all patients with LE and the particular oncological and autoimmune associations of MoS suggest two very different aetiopathogenesis.
Muñiz‐Castrillo et al. (Fri,) studied this question.